Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyAbout this site
Hepatobiliary surgery · Fudan University Shanghai Cancer Center · Shanghai

Dr. Luo Guopei罗国培

Associate Chief Physician

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Luo Guopei

Professional overview

An Associate Chief Physician in the Department of Pancreatic Surgery at Fudan University Shanghai Cancer Center, specializing in radical surgery and comprehensive treatment for pancreatic cancer, ampullary cancer, cholangiocarcinoma, and gallbladder cancer—including laparoscopic minimally invasive surgery.

SpecialtyHepatobiliary surgery
Clinical titleAssociate Chief Physician
Academic rolesLecturer
DepartmentPancreatic Surgery
HospitalFudan University Shanghai Cancer Center
CityShanghai

Areas of focus

Pancreatic cancerRadical surgery and comprehensive treatment, including laparoscopic minimally invasive surgery; extensive experience in diagnosing and treating CA19-9-normal pancreatic cancer and pancreatic cancer with abnormal blood glucose.

Background

  • 2008Joint-training Ph.D. program at University of California, Irvine
  • 2009Joint-training Ph.D. program at University of California, Irvine
  • 2011Young Investigator Award, American Pancreatic Association
  • 2014Shanghai Science and Technology Rising Star Program
  • 2015Shanghai Young Physician Training Program
  • 2016Outstanding Young Physician Award, Pancreatic Cancer Society of China Anti-Cancer Association (CACA)
  • 2018Outstanding Youth Talent Program, Fudan University Shanghai Cancer Center
  • 2019Wu Mengchao Youth Science and Technology Fund Award
  • 2022First Prize of Shanghai Medical Science and Technology Progress Award (second contributor)
  • 2022First Prize of China Anti-Cancer Association (CACA) Science and Technology Progress Award (second contributor)

Experience & recognition

  • Principal investigator of 6 national and provincial-level research projects, including 4 National Natural Science Foundation of China (NSFC) grants
  • Published nearly 90 SCI papers as first or corresponding author in journals including Journal of Clinical Oncology, Annals of Surgery, and International Journal of Cancer
  • SCI papers with highest impact factor over 44
  • Research on CA19-9 and Lewis antigen-based pancreatic cancer subtyping—including identification of the CA19-9 true-negative subgroup—contributed to updates in the U.S. NCCN guidelines for pancreatic tumors

Professional roles

  • Member, Pancreatic Cancer Society of Shanghai Anti-Cancer Association
  • Member, Tumor Biomarkers Society of Shanghai Anti-Cancer Association
  • Member, Multi-Regional Diagnosis and Treatment Working Group of the Pancreatic Cancer Society of Shanghai Anti-Cancer Association
  • Member, Chinese General Surgery Ascending Scholar Program

Frequently asked questions

What does Dr. Luo Guopei specialize in?

Radical surgery and comprehensive treatment for pancreatic cancer, ampullary cancer, cholangiocarcinoma, and gallbladder cancer—including laparoscopic minimally invasive surgery; extensive experience in diagnosing and treating CA19-9-normal pancreatic cancer and pancreatic cancer with abnormal blood glucose.

Which hospital and department is Dr. Luo Guopei in?

Department of Pancreatic Surgery at Fudan University Shanghai Cancer Center

Sources

Dr. Luo Guopei has not reviewed this page.